⌘K

Login Start Free

Home/Filings/4/0001437749-20-014799

4//SEC Filing

Kennedy Keith 4

Accession 0001437749-20-014799

CIK 0001384101other

View on SEC.gov Company Profile

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 5:47 PM ET

Size

21.1 KB

Accession

0001437749-20-014799

Insider Transaction Report

Form 4

Period: 2020-07-02

VERACYTE, INC.VCYT

Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2020-07-02$5.98/sh+2,800$16,744→ 158,398 total
Exercise/Conversion
Common Stock
2020-07-06$5.98/sh+10,075$60,249→ 162,726 total
Exercise/Conversion
Common Stock
2020-07-06$9.05/sh+15,416$139,515→ 200,309 total
Exercise/Conversion
Stock Option (right to buy)
2020-07-06−22,167→ 22,223 total
Exercise: $7.47Exp: 2026-12-05→ Common Stock (22,167 underlying)
Sale
Common Stock
2020-07-02$28.02/sh−5,747$161,040→ 152,651 total
Exercise/Conversion
Common Stock
2020-07-06$7.47/sh+22,167$165,587→ 184,893 total
Sale
Common Stock
2020-07-06$28.21/sh−80,677$2,276,172→ 119,632 total
Exercise/Conversion
Stock Option (right to buy)
2020-07-02−2,800→ 47,092 total
Exercise: $5.98Exp: 2028-03-01→ Common Stock (2,800 underlying)
Exercise/Conversion
Stock Option (right to buy)
2020-07-06−10,075→ 37,017 total
Exercise: $5.98Exp: 2028-03-01→ Common Stock (10,075 underlying)
Exercise/Conversion
Stock Option (right to buy)
2020-07-06−15,416→ 4,584 total
Exercise: $9.05Exp: 2027-03-02→ Common Stock (15,416 underlying)

Footnotes (6)

[F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 11, 2020.
[F2]Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.15. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
[F3]Represents weighted average sales price. Sale prices for the transactions range from $28.00 to $28.58. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
[F4]The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
[F5]The option began to vest on December 6, 2017 and vests at a rate of 1/36th per total number of shares subject to the award each month, subject to the continuing employment of the reporting person on the vesting date.
[F6]The option becomes exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1

filerCIK 0001543503

Filing Metadata

Form type: 4
Filed: Jul 6, 8:00 PM ET
Accepted: Jul 7, 5:47 PM ET
Size: 21.1 KB

View on SEC.gov